BILIARY ATRESIA
Clinical trials for BILIARY ATRESIA explained in plain language.
Never miss a new study
Get alerted when new BILIARY ATRESIA trials appear
Sign up with your email to follow new studies for BILIARY ATRESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver drug maralixibat tested for Long-Term safety in rare disease patients
Disease control CompletedThis study looked at the long-term safety of a drug called maralixibat in 52 people with cholestatic liver disease, including Alagille Syndrome and other rare conditions. Participants had already taken maralixibat in an earlier study. Researchers tracked side effects and how well…
Matched conditions: BILIARY ATRESIA
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Researchers dig into records to improve care for rare liver disease in kids
Knowledge-focused CompletedThis study reviewed medical records of 320 children with biliary atresia, a rare liver disease, treated at hospitals in the northeastern U.S. between 2012 and 2021. The goal was to find which factors lead to better outcomes, such as avoiding liver transplant or clearing jaundice.…
Matched conditions: BILIARY ATRESIA
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Timing is everything: new study seeks optimal age for Life-Saving baby liver surgery
Knowledge-focused CompletedThis study followed 200 babies with biliary atresia who had Kasai surgery at different ages to see which timing gives the best chance of keeping their own liver healthy for two years. Researchers grouped babies by surgery age (from under 28 days to 120 days) and tracked how many …
Matched conditions: BILIARY ATRESIA
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC